In patients with diabetic nephropathy, glomerulopathy is an important renal structural change. The kidney consists of four basic tissue types: vessels, glomeruli, tubules, and interstitium. Each ...

In a retrospective study of 3,228 adults with type 2 diabetic nephropathy, ESRD developed in 19.5% of subjects over a mean follow-up period of 2.8 years, which was 2.5 times the incidence of ...

Diabetic nephropathy is a type of kidney disease caused by long-standing diabetes. High blood sugar levels over time damage ...

A new study published in BMC Nephrology has found that elevated levels of high-sensitivity C-reactive protein (hs-CRP) are ...

Renal disease can regress and glomerular architecture can be remodeled in diabetic nephropathy. This finding in a few patient studies follows promising work in animal models, such as those with ...

Nephropathy refers to the deterioration of kidney function. When left untreated it leads to end-stage renal disease (ESRD), more commonly referred to as kidney failure, and death.

Achieved systolic blood pressure is the most potent predictor of renal outcomes in patients with diabetic nephropathy, a new analysis of the Irbesartan Diabetic Nephropathy Trial suggests. (Pohl M ...

Diabetic nephropathy, also known as diabetic kidney disease, is a slowly progressing condition that may affect people who have type 1 or type 2 diabetes. It progresses in stages ranging from 1 ...

Promising pipeline diabetic nephropathy therapies such as SER150, CU01, 2HPβCD, SC0062, WAL0921, AP 303, YG1805, CTA 382, and others are in different Phases of diabetic nephropathy clinical trials.

ACE inhibitors may help prevent diabetic nephropathy in those with type 2 diabetes. They are also the first-line treatment when diabetic nephropathy has already developed. Learn more here.

Diabetic nephropathy is a complication seen in both type 1 and type 2 diabetes. It develops when high blood sugar levels damage the small blood vessels in the kidneys, impairing their ability to ...